2020
DOI: 10.1186/s12884-020-03082-9
|View full text |Cite
|
Sign up to set email alerts
|

Improved clinical outcomes of preimplantation genetic testing for aneuploidy using MALBAC-NGS compared with MDA-SNP array

Abstract: Background: To assess whether preimplantation genetic testing for aneuploidy with next generation sequencing (NGS) outweighs single nucleotide polymorphism (SNP) array in improving clinical outcomes. Methods: A retrospective analysis of the clinical outcomes of patients who underwent PGT-A treatment in a single center from January 2013 to December 2017.A total of 1418 couples who underwent PGT-A treatment were enrolled, of which 805 couples used NGS for PGT-A, while the remaining 613 couples used SNP array for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 30 publications
0
12
0
Order By: Relevance
“…The cases in this article all use the SNP or NGS method, which is currently a relatively extensive method for the diagnosis of embryo chromosome abnormality ( 19 ). They can screen 23 pairs of chromosomes comprehensively, which has obvious advantages compared with FISH technique which can only carry out hybridization detection of a limited number of chromosomes ( 26 ). What is more, trophoblastic cell biopsy can not only control the damage to the embryo, but also ensure the accuracy of the sequencing results ( 27 ).…”
Section: Discussionmentioning
confidence: 99%
“…The cases in this article all use the SNP or NGS method, which is currently a relatively extensive method for the diagnosis of embryo chromosome abnormality ( 19 ). They can screen 23 pairs of chromosomes comprehensively, which has obvious advantages compared with FISH technique which can only carry out hybridization detection of a limited number of chromosomes ( 26 ). What is more, trophoblastic cell biopsy can not only control the damage to the embryo, but also ensure the accuracy of the sequencing results ( 27 ).…”
Section: Discussionmentioning
confidence: 99%
“…Friedenthal et al observed 548 and 368 PGT-A-FET cycles based on NGS and aCGH, respectively, and found that NGS can exclude more mosaic embryos, embryos with segmental aneuploidy, and trisomy embryos as well as yield better pregnancy outcomes [ 10 ]. Furthermore, Niu et al compared the clinical outcomes of 805 NGS-PGT-A cycles and 613 SNP array-PGT-A cycles, and showed that the clinical pregnancy rate and healthy live birth rate in the NGS-PGT-A group were significantly higher [ 11 ]. Moreover, the rate of miscarriage was lower in the NGS-PGT-A group, presumably because NGS can exclude more mosaic embryos [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, Niu et al compared the clinical outcomes of 805 NGS-PGT-A cycles and 613 SNP array-PGT-A cycles, and showed that the clinical pregnancy rate and healthy live birth rate in the NGS-PGT-A group were significantly higher [ 11 ]. Moreover, the rate of miscarriage was lower in the NGS-PGT-A group, presumably because NGS can exclude more mosaic embryos [ 11 ]. Consistent with this, a recent study based on 6427 blastocysts showed that NGS yielded a significantly higher mosaicism detection rate (23.3% vs 7.7%), and lower spontaneous abortion rate (6.33% vs 10.07%) than the SNP array in PGT cycles [ 23 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The TE cells in blastocysts from the RA-T group were analyzed for chromosome aneuploidy using SNP microarray analysis, as described previously (17). The next-generation sequencing was used for analyzing clinical PGT chromosome aneuploidy, which was described in a previous study (17).…”
Section: Chromosome Aneuploidy Analysismentioning
confidence: 99%